Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion

Figure 1

Soluble mediators of bone remodeling in the circulation of patients with PsA. Box-and-whisker plots showing concentrations of (a) Dkk-1, (b) M-CSF, (c) OPG, and (d) RANKL in healthy controls (HCs), patients with psoriasis (Ps) and patients with PsA. Box-and-whisker plots showing concentrations of (e) Dkk-1, (f) M-CSF, (g) OPG, and (h) RANKL in patients with psoriasis (Ps) and patients with nonerosive PsA, and patients with erosive PsA. Median values for RANKL for the healthy control, all PsA, and erosive PsA groups were 0.031 pmol/L. *P < 0.05; **P < 0.01; ***P < 0.001; one-way ANOVA with Dunn's multiple comparison test.

Back to article page